Description
A ROCK inhibitor (IC50s = 0.6 and 1.1 nM, respectively, for human ROCK-I and ROCK-II); selective for ROCK over MLCK and ZIP-kinase (IC50s = 7,400 and 4,100 nM, respectively), as well as 110 kinases in a panel at 1-10 µM, but does inhibit TRK and FLT3 (IC50s = 252 and 303 nM, respectively); reduces ROCK-II-induced MBS phosphorylation at 3 nM; inhibits phenylephrine-induced contraction of isolated rabbit saphenous artery (IC50 = 65 nM); decreases blood pressure in normotensive and hypertensive rats at 3 and 10 mg/kg; decreases right ventricular systolic pressure and total pulmonary resistance in a rat model of monocrotaline-induced pulmonary hypertension at 10 mg/kg per day
Formal name: 6-chloro-N4-[3,5-difluoro-4-[(3-methyl-1H-pyrrolo[2,3-b]pyridin-4-yl)oxy]phenyl]-2,4-pyrimidinediamine
Synonyms: Azaindole 1
Molecular weight: 402.8
CAS: 867017-68-3
Purity: ≥95%
Formulation: A solid
Product Type|Biochemicals|Kinase Inhibitors|ROCK||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cardiovascular System|Cardiovascular Diseases|Hypertension||Research Area|Cell Biology|Cytoskeleton & Motor Proteins